IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BOSSI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.344
EU - Europa 3.653
AS - Asia 3.524
SA - Sud America 29
AF - Africa 27
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.294
CN - Cina 1.083
SG - Singapore 977
HK - Hong Kong 896
UA - Ucraina 842
IT - Italia 448
DE - Germania 416
IE - Irlanda 381
PL - Polonia 340
TR - Turchia 323
RU - Federazione Russa 316
EE - Estonia 295
GB - Regno Unito 188
FI - Finlandia 157
SE - Svezia 89
ID - Indonesia 80
VN - Vietnam 60
IN - India 53
AT - Austria 47
CA - Canada 41
CZ - Repubblica Ceca 37
FR - Francia 30
NL - Olanda 21
AU - Australia 16
BR - Brasile 13
EG - Egitto 11
BE - Belgio 9
CH - Svizzera 9
JP - Giappone 7
MY - Malesia 7
AR - Argentina 6
LY - Libia 5
MA - Marocco 5
MX - Messico 5
ES - Italia 4
EU - Europa 4
HR - Croazia 4
IL - Israele 4
LK - Sri Lanka 4
MK - Macedonia 4
TH - Thailandia 4
CO - Colombia 3
IR - Iran 3
KG - Kirghizistan 3
RO - Romania 3
AZ - Azerbaigian 2
DK - Danimarca 2
EC - Ecuador 2
IQ - Iraq 2
IS - Islanda 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 18.599
Salva come PNG Salva come JPEG
Città #
Fairfield 2.231
Ashburn 1.087
Seattle 903
Woodbridge 898
Hong Kong 890
Jacksonville 846
Houston 771
Singapore 710
Cambridge 694
Wilmington 668
Princeton 636
Chandler 416
Dublin 339
Warsaw 337
New York 327
Istanbul 309
Tallinn 295
Ann Arbor 282
Beijing 220
Des Moines 157
Nanjing 157
San Diego 150
Helsinki 140
Brescia 107
Moscow 97
Jakarta 77
Shenyang 70
London 63
Changsha 61
Shanghai 60
Dong Ket 58
Nanchang 55
Jinan 53
Hebei 52
Milan 50
Jiaxing 49
Nuremberg 48
Tianjin 48
Menlo Park 43
Pune 40
Los Angeles 37
Brno 33
Rome 31
Kilburn 26
Ningbo 26
Toronto 23
Norwalk 22
Vienna 21
Taizhou 19
Hangzhou 18
Romola 18
Guangzhou 17
Boardman 16
Haikou 16
Munich 16
San Francisco 16
Zhengzhou 14
Dearborn 13
Rende 13
Frankfurt am Main 12
New Bedfont 12
Cairo 11
Lanzhou 11
Washington 11
Chiswick 10
Lappeenranta 10
Canberra 9
Fort Worth 9
Verona 9
Hanover 8
Prineville 8
Brooklyn 7
Brussels 7
Calcinate 7
Cazzago San Martino 7
Hounslow 7
Santa Clara 7
Fuzhou 6
Melbourne 6
Taiyuan 6
Turin 6
Augusta 5
Dalmine 5
Lancaster 5
Leawood 5
Prescot 5
Wandsworth 5
Amsterdam 4
Arezzo 4
Berlin 4
Bonn 4
Chicago 4
Paris 4
Petaling Jaya 4
Phoenix 4
Redwood City 4
Tokyo 4
Acton 3
Benghazi 3
Bishkek 3
Totale 15.154
Salva come PNG Salva come JPEG
Nome #
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 198
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 173
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 171
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 159
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 150
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 150
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 135
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 128
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 126
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 121
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 116
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 116
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 115
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 111
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 110
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 109
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 104
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 103
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 102
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 101
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 101
Investigational drugs for head and neck cancer 101
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 100
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 100
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 97
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 94
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 93
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 92
Hope in cancer patients: the relational domain as a crucial factor 92
The role of systemic therapy in the management of sinonasal cancer: A critical review 92
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 91
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 91
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 88
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 88
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 88
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 87
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 87
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 86
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 86
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 86
The Case Volume Issue in Head and Neck Oncology 86
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 85
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 85
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 85
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 85
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 84
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 84
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 84
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 82
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 82
TP53 mutations in head and neck cancer 82
Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma 82
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 82
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 81
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 81
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 81
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 81
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 81
Multikinase inhibitors in thyroid cancer 81
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options 80
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting 80
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 80
Receptor Tyrosine Kinase Profiles and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma 80
Pain related to cancer treatments and diagnostic procedures: a no man's land? 80
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology 80
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 80
Comments on "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure" by Chan and Coll 79
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 79
Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs) 79
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 79
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 79
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 78
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 78
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 78
Cisplatin dose intensity correlates with outcome in patients with locally advanced head and neck squamous cell carcinoma receiving concurrent cisplatin based chemoradiation: a multi-institutional experience 78
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 78
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 78
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 77
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 77
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 77
Induction chemotherapy within a multimodality treatment of nasal cavity and ethmoid sinus malignant epithelial tumours: report of an homogeneous series of patients 77
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 76
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 76
OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TREATED WITH RADIOTHERAPY OR RADIOCHEMOTHERAPY: PROGNOSTIC ROLE OF TP53 AND HPV STATUS 76
Isolating p16-positive/HPV-negative Oropharyngeal Cancer: An Effort Worth Making 76
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 75
Gastrointestinal toxicities from targeted therapies: measurement, duration and impact 75
Emerging tyrosine kinase inhibitors for head and neck cancer 75
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 75
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 75
Rapid-Onset Opioids for the Treatment of Breakthrough Cancer Pain: Two Cases of Drug Abuse 75
Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review 74
New insights in chemotherapy 74
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis 74
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 74
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 74
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 73
Global cancer control: responding to the growing burden, rising costs and inequalities in access 73
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 73
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 72
Totale 9.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020980 0 0 0 0 0 0 0 0 301 383 206 90
2020/20215.199 64 476 246 999 298 729 152 519 345 723 284 364
2021/20222.337 116 253 56 283 109 212 76 202 120 195 201 514
2022/20231.518 359 89 46 113 92 464 8 96 144 26 37 44
2023/20242.385 64 36 117 107 122 577 90 137 665 39 33 398
2024/20252.886 32 21 69 1.028 543 536 336 134 187 0 0 0
Totale 19.009